Skip to Main Content

Paper Details

A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
Oncologist
5
2021
Author NameAffiliation
Timothy M KuzelRush University Medical Center
  • 1 - 1

Datasets

Release 1.2